EXERCISE T1D CGM POSITION STATEMENT

Date: July 24, 2020 @ 20.30 (Time Zone: GMT+4, Dubai Time)
Presented by: Dr. Othmar Moser & Dr. Ramzi Ajjan
Moderated by: Dr. Asma Deeb

Supported By

Prof. Asma Deeb
President, ASPED
Consultant and Chief of Pediatric Endocrinology
Sheikh Shakbout Medical City
Abu Dhabi, United Arab Emirates

Faculty Profile:

Prof Asma Deeb is the chief of Paediatric Endocrinology and the chair of research and ethics committee at Mafraq hospital, Abu Dhabi. She is a clinical professor at the Gulf University, UAE.

Prof Deeb is the president of the Arab Society of Paediatric Endocrinology and Diabetes (ASPED) and the ASPED representative of the Global Pediatric Endocrinology Association.

She is the Chair of communication of the European Society of Paediatric Endocrinology (ESPE) and a member in the advisory board of the International Society of the Pediatric and Adolescent Diabetes (ISPAD).

Prof Deeb trained in the UK and obtained an MD degree from the University of Newcastle Upon Tyne. She held a position of ‘Clinical lecturer in Paediatric Endocrinology’ in the University of Cambridge.

She is a keen researcher and has various publications in peer-review journals. Her special interest in disorders of sexual differentiation, molecular endocrinology and the use of technology in Diabetes treatment

Dr. Ramzi Ajjan
Consultant Endocrinologist. Associate Professor
The Leeds Teaching Hospitals NHS Trust

Faculty Profile:

RA Ajjan (FRCP, MMed.Sci, PhD) is a Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. Prof. Ajjan was successful at obtaining a Clinician Scientist Award from the NIHR in 2005 and developed a spectrum of basic, translational and clinical research studies. His work collectively aims to reduce cardiovascular complications in diabetes by improving glycaemia and ameliorating the thrombotic environment.

His clinical studies have focussed on optimising glycaemic control by reducing high glucose levels, while avoiding hypoglycaemia and keeping glucose variability to a minimum. His translational work aims to uncover novel therapeutic targets to reduce the hypofibrinolytic environment in diabetes, a key abnormality in this condition.

He has over 150 publications including original articles, reviews and book chapters. His clinical practice concentrates on young adults with diabetes as well as older individuals at high risk of vascular disease. Also, he runs the regional multidisciplinary thyroid eye disease clinic.

He is local R&D lead for Diabetes/Endocrinology, regional clinical research network co-lead for diabetes, endocrine and metabolic conditions, and deputy Chair of a Clinical Study Group at Diabetes UK. He is an Associate Editor of Diabetes and Vascular Disease Research, and member of the editorial board of International Journal of Molecular Sciences.

Dr. Othmar Moser
Senior Scientist
Cardiovascular Diabetology Research Group
Medical University of Graz
Graz, Austria

Faculty Profile:

Coming Soon
  • 20.30-20:35

    Introduction on ASPED
    Presented by Dr. Asma Deeb

  • 20:35-20:40

    Introduction on Supporter
    Presented by Supporter

  • 20:40-21:10

    Use of isCGM for Exercise in Type 1 Diabetes; EASD & ISPAD Consensus Statement
    Presented by Dr. Othmar Moser

  • 21:10-21:40

    Approach to AGP interpretation; Report Analysis and Clinical Case Scenarios
    Moderated by Dr. Ramzi Ajjan

  • 21:40-22:00

    Question & Answer
    Moderated by Dr. Asma Deeb